ZeroStack Corp. (ZSTK)
4.86
+0.02
(+0.41%)
USD |
NASDAQ |
Oct 02, 16:00
4.85
-0.01
(-0.21%)
After-Hours: 20:00
ZeroStack Gross Profit Margin (Quarterly) : -7.63% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.63% |
| March 31, 2026 | -8.17% |
| December 31, 2025 | -27.94% |
| September 30, 2025 | -14.91% |
| June 30, 2025 | -6.14% |
| March 31, 2025 | -7.63% |
| December 31, 2024 | -42.30% |
| September 30, 2024 | -14.49% |
| June 30, 2024 | 3.50% |
| March 31, 2024 | 8.14% |
| December 31, 2023 | 2.26% |
| Date | Value |
|---|---|
| September 30, 2023 | 13.21% |
| June 30, 2023 | -4.26% |
| March 31, 2023 | 0.81% |
| December 31, 2022 | -4.19% |
| September 30, 2022 | 12.17% |
| June 30, 2022 | -8.57% |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | -62.73% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Medical Marijuana, Inc. | 83.04% |
| Interpace Biosciences, Inc. | 61.91% |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | -- |
| Stella Diagnostics, Inc. | -14.09% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -459.7% |
| Return on Assets | -294.0% |
| Return on Invested Capital | -334.4% |
| Profit Margin (Quarterly) | -180.2% |
| Operating Margin (Quarterly) | -15.08% |
| Return on Net Operating Assets | -1.11K% |